The FDA is informing healthcare professionals that preliminary results from a recently completed clinical study suggest that a 32mg single intravenous dose of ondansetron (Zofran; GlaxoSmithKline and ...

April 29, 2002 — Ondansetron is safe and effective in reducing the vomiting associated with acute gastroenteritis, according to the results of a randomized trial published online in the April issue of ...

SAN FRANCISCO – Haloperidol may be a better option than the old standby ondansetron to treat certain patients with vomiting and nausea in the emergency department (ED), according to a small ...

Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. One hundred forty-six patients received a single 20-mg IV dose of dexamethasone over 15 minutes ...

WASHINGTON -- The 32-mg dose of the anti-nausea drug ondansetron (Zofran) has been pulled from the market because of concerns about cardiac problems, the FDA announced Tuesday. Ondansetron is approved ...

April 7, 2005 — The U.S. Food and Drug Administration (FDA) has approved an intravenous formulation of esomeprazole magnesium for the short-term treatment of gastroesophageal reflux disease in ...

Ondansetron improves outcomes when administered in emergency departments to children with acute gastroenteritis–associated vomiting. It is commonly prescribed at discharge to reduce symptoms, but ...

Ondansetron, marketed under the name Zofran, is a medicine that is primarily given to patients to help stop nausea and vomiting caused by cancer treatments. This medicine is also used to help manage ...

The FDA has issued an alert to health care professionals against the use of certain intravenous bags of metronidazole, ondansetron and ciprofloxacin because of potential contamination. The warning was ...